Modulators of induction of plasminogen activator inhibitor type-1 in HepG2 cells by transforming growth factor-β

Coronary Artery Disease

Volumn 22, Issue 7, 2011, Pages 468-478

  Nakayama, Naomi ^a   Nakamura, Tomomi ^a   Okada, Hiromi ^a   Iwaki, Soichiro ^a   Sobel, Burton E ^b   Fujii, Satoshi ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

curcumin; oxidative stress; plasminogen activator inhibitor type 1; statin; transforming growth factor

Indexed keywords

CARBOXY 2,7 DICHLORODIHYDROFLUORESCEIN; CARBOXYFLUORESCEIN; CELL PROTEIN; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYPHENOL; PROTEIN NOX3; PROTEIN P22; RAC PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SIMVASTATIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; FIBROSIS; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; BINDING SITES; CURCUMIN; GENES, REPORTER; HEP G2 CELLS; HUMANS; LIVER; MEMBRANE PROTEINS; NADPH OXIDASE; NF-KAPPA B; OXIDATIVE STRESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; RAC GTP-BINDING PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; SIMVASTATIN; SMAD PROTEINS; TIME FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 80053635010     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32834a3817     Document Type: Article

References (43)

1. Hopkins WE, Fujii S, Sobel BE. Synergistic induction of plasminogen activator inhibitor type-1 in HepG2 cells by thrombin and transforming growth factor b. Blood 1992; 79:75-81.
2. Schneider DJ, Sobel BE. Diabetes and thrombosis. In: Johnstone MT, Veves A, editors. Diabetes and cardiovascular disease. 3rd ed. Totowa: Humana Press; 2009. pp. 107-128.
3. Sobel BE, Taatjes DJ, Schneider DJ. Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2003; 23:1979-1989. (Pubitemid 37433189)
4. Zaman AKMT French CJ, Schneider DJ, Sobel BE. A profibrotic effect of plasminogen activator inhibitor type-1 (PAI-1) on the heart (Featured Article). Exp Biol Med 2009; 234:246-254.
5. Rosenbloom J, Castro SV, Jimenez SA. Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies. Ann Intern Med 2010; 152:159-166.
6. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214:199-210. (Pubitemid 351160157)
7. Ghosh AK, Vaughan DE. PAI-1 in tissue fibrosis. J Cell Physiol 2011. [Epub ahead of print]
8. Sato Y, Dong J, Imagawa S, Ishimori N, Furumoto T, Tsutsui H, Sobel BE, Fujii S. Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1. Coron Artery Dis 2008; 19: 355-361.
9. Vulin AJ, Stanley FM. Oxidative stress activates the plasminogen activator inhibitor type 1 (PAI-1) promoter through an AP-1 response element and cooperates with insulin for additive effects on PAI-1 transcription. J Biol Chem 2004; 279:25172-25178. (Pubitemid 38756767)
10. Tawfik HE, El-Remessy AB, Matragoon S, Ma G, Caldwell RB, Caldwell RW. Simvastatin improves diabetes-induced coronary endothelial dysfunction. J Pharmacol Exp Ther 2006; 319:386-395. (Pubitemid 44455146)
11. Kayanoki Y, Fujii J, Suzuki K, Kawata S, Matsuzawa Y, Taniguchi N. Suppression of antioxidative enzyme expression by transforming growth factor-b 1 in rat hepatocytes. J Biol Chem 1994; 269:15488-15492. (Pubitemid 24202131)
12. Smith MR, Gangireddy SR, Narala VR, Hogaboam CM, Standiford TJ, Christensen PJ, et al. Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2010; 298:L616-L625.
13. 0-untranslated region of the PAI-1 gene and its pharmacologic implications. Coron Artery Dis 2010; 21:144-150.
14. Dong J, Fujii S, Imagawa S, Matsumoto S, Matsushita M, Todo S, et al. IL-1 and IL-6 induce hepatocyte plasminogen activator inhibitor-1 expression through independent signaling pathways converging on C/EBPd. Am J Physiol Cell Physiol 2007; 292:C209-C215. (Pubitemid 46115131)
15. Kaminaga Y, Nagatsu A, Akiyama T, Sugimoto N, Yamazaki T, Maitani T, Mizukami H. Production of unnatural glucosides of curcumin with drastically enhanced water solubility by cell suspension cultures of Catharanthus roseus. FEBS Lett 2003; 555:311-316. (Pubitemid 37486047)
16. Dong J, Fujii S, Li H, Nakabayashi H, Sakai M, Nishi S, et al. Interleukin-6 and mevastatin regulate plasminogen activator inhibitor-1 through CCAAT/enhancer-binding protein-d. Arterioscler Thromb Vasc Biol 2005; 25: 1078-1084. (Pubitemid 40627858)
17. phox-dependent manner: its regulation by oxidase organizers and activators. J Biol Chem 2005; 280:23328-23339. (Pubitemid 40853246)
18. Jeong WI, Do SH, Yun HS, Song BJ, Kim SJ, Kwak WJ, et al. Hypoxia potentiates transforming growth factor-b expression of hepatocyte during the cirrhotic condition in rat liver. Liver Int 2004; 24:658-668.
19. Paternostro C, David E, Novo E, Parola M. Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases. World J Gastroenterol 2010; 16:281-288.
20. De Bleser PJ, Xu G, Rombouts K, Rogiers V, Geerts A. Glutathione levels discriminate between oxidative stress and transforming growth factor-b signaling in activated rat hepatic stellate cells. J Biol Chem 1999; 274:33881-33887. (Pubitemid 129511715)
21. Cool RH, Merten E, Theiss C, Acker H. Rac1 and not Rac2, is involved in the regulation of the intracellular hydrogen peroxide level in HepG2 cells. Biochem J 1998; 332:5-8. (Pubitemid 28239312)
22. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidase: physiology and pathophysiology. Physiol Rev 2007; 87:245-313. (Pubitemid 46209993)
23. Sumimoto H. Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J 2008; 275: 3249-3277. (Pubitemid 351813551)
24. Murillo MM, Carmona-Cuenca I, Del Castillo G, Ortiz C, Roncero C, Sánchez A. Activation of NADPH oxidase by transforming growth factor-b in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-kB-dependent mechanism. Biochem J 2007; 405:251-259. (Pubitemid 47075160)
25. Choi SS, Witek RP, Yang L, Omenetti A, Syn WK, Moylan CA, et al. Activation of Rac1 promotes hedgehog-mediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cells. Hepatology 2010; 52:278-290.
26. Miyazono K, Suzuki H, Imamura T. Regulation of TGF-b signaling and its roles in progression of tumors. Cancer Sci 2003; 94:230-234. (Pubitemid 36575887)
27. Shi Y, Massagué J. Mechanisms of TGF-b signaling from cell membrane to the nucleus. Cell 2003; 113:685-700. (Pubitemid 36724933)
28. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGFb-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 1998; 17:3091-3100. (Pubitemid 28254381)
29. Köhler HB, Knop J, Martin M, de Bruin A, Huchzermeyer B, Lehmann H, et al. Involvement of reactive oxygen species in TNF-a mediated activation of the transcription factor NF-kB in canine dermal fibroblasts. Vet Immunol Immunopathol 1999; 71:125-142. (Pubitemid 29428038)
30. Vayalil PK, Iles KE, Choi J, Yi AK, Postlethwait EM, Liu RM. Glutathione suppresses TGF-b-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter. Am J Physiol Lung Cell Mol Physiol 2007; 293:1281-1292.
31. 2 and tumor necrosis factor-a induce differential binding of the redox-responsive transcription factors AP-1 and NF-kB to the interleukin-8 promoter in endothelial and epithelial cells. J Biol Chem 1998; 273:32670-32678. (Pubitemid 28557650)
32. Gloire G, Legrand-Poels S, Piette J. NF-kB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 2006; 72:1493-1505. (Pubitemid 44666727)
33. Perkins ND. Integrating cell-signaling pathways with NF-kB and IKK function. Nat Rev Mol Cell Biol 2007; 8:49-62. (Pubitemid 46012014)
34. Bosma PJ, Kooistra T. Different induction of two plasminogen activator inhibitor 1 mRNA species by phorbol ester in human hepatoma cells. J Biol Chem 1991; 266:17845-17850.
35. Fattal PG, Schneider DJ, Sobel BE, Billadello JJ. Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1. J Biol Chem 1992; 267: 12412-12415.
36. Shetty S, Velusamy T, Shetty RS, Marudamuthu AS, Shetty SK, Florova G, et al. Posttranscriptional regulation of plasminogen activator inhibitor-1 expression in human pleural mesothelial cells. Am J Respir Cell Mol Biol 2010; 43:358-367.
37. Rikitake Y, Liao JK. Rho GTPases statins, and nitric oxide. Circ Res 2005; 97:119-127.
38. Aggarwal BB. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr 2010; 30:173-199.
39. Gaedeke J, Noble NA, Border WA. Curcumin blocks multiple sites of the TGF-b signaling cascade in renal cells. Kidney Int 2004; 66:112-120. (Pubitemid 38870087)
40. Balasubramanyam K, Varier RA, Siddappa NB, Ranga U, Kundu TK. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 2004; 279:51163-51171. (Pubitemid 40017859)
41. Zhang J, Xu Y, Pan L, Chen T, Chen Z, Zhao R. Effect of simvastatin on collagen I deposition in non-infarcted myocardium: role of NF-kB and osteopontin. Can J Physiol Pharmacol 2010; 88:1026-1034.
42. Behnes M, Hoffmann U, Lang S, Weiss C, Ahmad-Nejad P, Neumaier M, et al. Transforming growth factor b1 in atrial fibrillation and acute congestive heart failure. Clin Res Cardiol 2011; 100:335-342.
43. Grainger DJ. TGF-b and atherosclerosis in man. Cardiovasc Res 2007; 74:213-222.